SCHEMBL25060006

SCHEMBL25060006

CNc1cccc(-c2cccc(OC)c2)c1C#N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.54
ADORA1 P30542 4/20 0.54
BTK Q06187 1/20 0.52
PDCD1 Q15116 1/20 0.50
CD274 Q9NZQ7 1/20 0.50
GRM2 Q14416 1/20 0.47
ADORA2B P29275 2/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 3/20 0.46
RXFP1 Q9HBX9 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
SQOR Q9Y6N5 1/20 0.46
LRRK2 Q5S007 1/20 0.45
GLA P06280 2/20 0.44
MAPT P10636 1/20 0.43
TGFBR2 P37173 1/20 0.43
PGR P06401 1/20 0.43
AR P10275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573051 0.83 ADORA2A (0.55) ADORA2AADORA1BTKPDCD1CD274
SCHEMBL19018356 0.80 ADORA1 (0.47) ADORA2AADORA1CD274ADORA2BHPGD
SCHEMBL621540 0.79 ADORA1 (0.56) ADORA2AADORA1BTKPDCD1CD274
SCHEMBL5098820 0.79 ADORA2A (0.47) ADORA2AADORA1BTKTP53HPGD
SCHEMBL7091942 0.75 NPC1 (0.45) ADORA2AADORA1ADORA2BHTTKDM4E
SCHEMBL9469502 0.74 ALDH1A1 (0.57) ADORA2AADORA1ADORA2BTP53HPGD
SCHEMBL2020140 0.72 ABL1 (0.59) ADORA2AADORA1TP53ALDH1A1GAA
SCHEMBL952649 0.72 HTR7 (0.49) ADORA2AADORA1PDCD1CD274GRM2
SCHEMBL19731928 0.71 CD274 (0.63) ADORA1PDCD1CD274HTTKDM4E
SCHEMBL9905199 0.71 ALDH1A1 (0.49) ADORA2AADORA1BTKTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4137489-A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS Incyte Corporation (US) 2023-02-22 EP disclosed